Zogenix, Inc. (ZGNX) News Headlines

▮ More

Date

Headline

5/26/2020 1:38:19 AM Biotech Stocks Facing FDA Decision In June 2020

4/20/2020 8:13:11 AM Zogenix Appoints Shawnte Mitchell To Role Of EVP, General Counsel And Secretary

2/27/2020 11:37:07 PM FDA Nod For BHVN's Drug, IBIO On Watch, SGMO Soars On Biogen Deal

2/27/2020 10:47:57 AM Stock Alert: Zogenix Loses 14%

2/7/2020 9:54:08 AM Stock Alert: Zogenix (ZGNX) Plunges 29%

12/17/2019 7:41:25 PM Zogenix : FINTEPLA Shows Dose-dependent Reduction In Convulsive Seizure Frequency In Dravet Syndrome Patients

11/26/2019 1:45:46 AM CCXI Is Red Hot, ZGNX On Watch, FDA Snubs ADMP

11/25/2019 8:05:23 AM Zogenix Reports FDA Acceptance For Filing Of NDA, Priority Review For FINTEPLA

10/7/2019 8:05:54 AM Zogenix Subsidiary, Modis Therapeutics, Presents Positive Top-line Results From Pivotal Phase 2 RETRO Study

9/26/2019 7:16:08 AM Zogenix Resubmits New Drug Application For FINTEPLA

9/9/2019 8:13:20 AM Zogenix Completes Acquisition Of Modis Therapeutics

8/26/2019 7:09:51 AM Zogenix To Acquire Modis Therapeutics

6/27/2019 9:43:55 PM 5 Top Gainers In Healthcare Sector (DOVA, ATOS, ZGNX...)

6/27/2019 8:15:22 AM Zogenix Announces FDA Agreement To Proceed With Resubmission Of FINTEPLA NDA

4/9/2019 2:47:55 AM CNCE Hits A Low, UTHR Throws In The Towel On PAH Drug, ZGNX Plunges On FDA Snub

4/8/2019 11:21:43 PM Zogenix Plunges After FDA Refuses To Review Seizure Drug

4/8/2019 5:11:35 PM Zogenix Shares Down 32% After FDA Refuses To Review Seizure Drug

2/6/2019 8:10:24 AM Zogenix Submits NDA To FDA And MAA To European Medicines Agency For FINTEPLA For Dravet Syndrome

12/3/2018 9:23:18 AM Zogenix Reports Positive Phase 3 Trial Results On Efficacy, Safety Of FINTEPLA In Dravet Syndrome

12/2/2018 10:01:43 AM Zogenix Presents Positive Findings On The Impact Of Treatment With FINTEPLA